Recruiting Migraine Studies in Gulf Breeze
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
The main goal of the study is to assess the long-term safety of eptinezumab on children and adolescents ages 6 to 17 with chronic or episodic migraine....
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
A migraine is a moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other sy...
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to...
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
The main goal of this trial is to learn whether eptinezumab helps reduce the number of days with episodic migraine in pediatric participants....
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. The primary objective is t...
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
To find out if eptinezumab is better than placebo (normal saline solution) in lowering the number of days with migraine in young people ages 12 to 17 with chronic migraine....
About Migraine Clinical Trials in Gulf Breeze
Migraine is a neurological condition characterized by intense, debilitating headaches often accompanied by nausea, light sensitivity, and visual disturbances. It affects about 1 billion people globally and is a leading cause of disability. Treatments include preventive medications, acute therapies, and newer CGRP-targeting drugs.
There are currently 6 migraine clinical trials recruiting participants in Gulf Breeze, FLORIDA. These studies are seeking a combined 2,370 participants. Research is being sponsored by H. Lundbeck A/S, AbbVie, Eli Lilly and Company. Clinical trial participation is free and participants receive study-related medical care at no cost.
Migraine Clinical Trials in Gulf Breeze — FAQ
Are there migraine clinical trials in Gulf Breeze?
Yes, there are 6 migraine clinical trials currently recruiting in Gulf Breeze, FLORIDA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Gulf Breeze?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Gulf Breeze research site will contact you about next steps.
Are clinical trials in Gulf Breeze free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Gulf Breeze studies also compensate for your time and travel.
What migraine treatments are being tested?
The 6 active trials in Gulf Breeze are testing new therapies including novel drugs, biologics, and treatment approaches for migraine.
Data updated March 2, 2026 from ClinicalTrials.gov